Previous studies have shown that administration of exogenous recombinant GDF11 to aged mice reduces cardiac hypertrophy (Loffredo et al, 2013), and fetal cardiac GDF8 has also been implicated in early-stage heart development (Sharma et al, 1999). This evidence concerns the gene MSTN and cardiac hypertrophy.